Physician profile
William E Otero
NPI 1588776884
$1,056.20
in general payments reported to CMS, 2019-2025
8 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $179 · 2020: $56.39 · 2021: $240 · 2022: $86.02 · 2023: $20.66 · 2024: $340 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $494.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $292.60 | 2020-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $265.21 | 2019-2025 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $206.46 | 2021-2025 | Jardiance |
| Coloplast Corp | $147.84 | 2019 | |
| Amgen INC. | $74.64 | 2023-2024 | Otezla, Repatha |
| Merck Sharp & Dohme LLC | $37.59 | 2020-2021 | |
| Evoke Pharma, INC. | $17.74 | 2021 | |
| Hologic Sales and Service, LLC | $14.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Otero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.